Teladoc Health, Inc. (NYSE:TDOC) Short Interest Update

Teladoc Health, Inc. (NYSE:TDOC) was the target of a significant decline in short interest in March. As of March 31st, there was short interest totalling 21,720,000 shares, a decline of 19.0% from the March 15th total of 26,820,000 shares. Based on an average daily volume of 7,660,000 shares, the short-interest ratio is presently 2.8 days. Approximately 12.7% of the shares of the company are sold short.

Wall Street Analysts Forecast Growth

A number of research analysts have recently issued reports on TDOC shares. Bank of America dropped their target price on Teladoc Health from $9.50 to $8.00 and set a “neutral” rating on the stock in a report on Friday, April 11th. The Goldman Sachs Group reduced their price objective on shares of Teladoc Health from $16.00 to $13.00 and set a “buy” rating for the company in a research report on Monday, March 3rd. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research note on Thursday, February 27th. Oppenheimer decreased their price target on Teladoc Health from $14.00 to $12.00 and set an “outperform” rating on the stock in a research note on Friday, January 24th. Finally, Piper Sandler decreased their target price on shares of Teladoc Health from $13.00 to $12.00 and set an “overweight” rating on the stock in a research report on Thursday, February 27th. Eleven equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and an average target price of $10.94.

Insider Transactions at Teladoc Health

In other Teladoc Health news, insider Adam C. Vandervoort sold 11,011 shares of the firm’s stock in a transaction on Thursday, March 20th. The shares were sold at an average price of $8.42, for a total transaction of $92,712.62. Following the transaction, the insider now directly owns 64,308 shares of the company’s stock, valued at approximately $541,473.36. This trade represents a 14.62 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.95% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of hedge funds have recently made changes to their positions in TDOC. Whipplewood Advisors LLC purchased a new position in shares of Teladoc Health in the 4th quarter worth $29,000. Versant Capital Management Inc grew its stake in Teladoc Health by 313.8% during the fourth quarter. Versant Capital Management Inc now owns 3,219 shares of the health services provider’s stock worth $29,000 after buying an additional 2,441 shares during the period. Lindbrook Capital LLC increased its holdings in Teladoc Health by 78.9% in the 4th quarter. Lindbrook Capital LLC now owns 3,654 shares of the health services provider’s stock valued at $33,000 after purchasing an additional 1,612 shares in the last quarter. Sterling Capital Management LLC raised its position in Teladoc Health by 776.7% in the fourth quarter. Sterling Capital Management LLC now owns 4,629 shares of the health services provider’s stock valued at $42,000 after purchasing an additional 4,101 shares during the period. Finally, Pilgrim Partners Asia Pte Ltd acquired a new stake in Teladoc Health during the 4th quarter valued at $60,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Trading Down 1.1 %

TDOC traded down $0.08 during trading on Friday, hitting $6.83. The company’s stock had a trading volume of 3,830,334 shares, compared to its average volume of 6,247,637. The stock has a market cap of $1.20 billion, a PE ratio of -1.18 and a beta of 1.73. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.73 and a quick ratio of 1.69. Teladoc Health has a twelve month low of $6.61 and a twelve month high of $15.21. The firm’s 50 day moving average price is $9.17 and its 200-day moving average price is $9.63.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, February 26th. The health services provider reported ($0.28) earnings per share for the quarter, missing the consensus estimate of ($0.21) by ($0.07). Teladoc Health had a negative return on equity of 10.06% and a negative net margin of 37.91%. The company had revenue of $640.49 million for the quarter, compared to analysts’ expectations of $639.44 million. On average, analysts expect that Teladoc Health will post -1.16 earnings per share for the current year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.